YH004 / Biocytogen  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
YH004 / Biocytogen
NCT05040932: Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Completed
1
8
RoW
YH004
Eucure (Beijing) Biopharma Co., Ltd
Cancer
07/23
07/23
NCT05564806: Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Recruiting
1
38
RoW
YH004
Eucure (Beijing) Biopharma Co., Ltd
Advanced Solid Tumors, Relapsed Or Refractory Non-Hodgkin Lymphoma
10/25
02/26

Download Options